Research programme: non-hormonal female sexual dysfunction therapeutics - Intra-Cellular TherapiesAlternative Names: ITI-003
Latest Information Update: 08 Apr 2014
At a glance
- Originator Intra-Cellular Therapies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Female sexual dysfunction
Most Recent Events
- 18 Sep 2007 Preclinical trials in Female sexual dysfunction in USA (unspecified route)